Get In Touch with iOrgan Bio
Please tell us a little bit about yourself and why you'd like to get connected. iOrgan Bio + SOSV will follow up with you via email.
iOrgan Bio is redefining how human cells are made by turning biology into an industrial, data-defined process. Built on technology from Weill Cornell Medicine and the Terasaki Institute, the company’s CellForge platform uses AI-driven, multi-omics feedback control to guide cells toward exact target states without genetic modification. This enables reproducible manufacturing of any human cell type or organoid with unmatched bioequivalence and cost efficiency. By standardizing living cell production, iOrgan Bio provides the foundation for scalable disease modeling, regenerative medicine, and cell therapy manufacturing—at up to 100× lower cost than today’s methods. Led by experts from MD Anderson, Weill Cornell, and top biotech companies, iOrgan Bio is transforming human cells from bespoke materials into reliable, mass-manufactured products.
Please tell us a little bit about yourself and why you'd like to get connected. iOrgan Bio + SOSV will follow up with you via email.
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.